Australian generic pharmaceutical company founded in 2003 in South Melbourne, formerly the Australia and Southeast Asia generics business of Strides Arcolab, acquired by Watson Pharmaceuticals (later Actavis) for AU$375 million in 2012.
No comments available.
Leave your rating & comment